Hexaspray ae. d / local approx. 2.5% fl. 30g

Hexasprey contains 750 mg of the active ingredient biclotymol in one 30-gram vial.

Name ENG

HEXASPRAY

Clinical and pharmacological group

Antiseptic for topical use in ENT practice

ATX code

Other drugs

Dosage

2.5% x 30g

Structure

Aerosol for topical application in the form of a homogeneous suspension of white with a yellowish sheen, with a characteristic odor of anise.

1 fl.

(30 g).

biclotymol 750 mg.

Excipients: benzyl alcohol, disodium edetate, methylparaben, anise oil, ammonium glycyrrhizinate, sodium saccharin, Avicel RC 591 (microcrystalline cellulose and sodium carboxymethylcellulose), soy lecithin, glycerol, ethanol 95%, purified water.

Indications

Infectious and inflammatory diseases of the oral cavity, pharynx, larynx, caused by pathogens sensitive to biclotymol.

Contraindications

Children under 6 years old

hypersensitivity to the components of the drug.

INN / Active ingredient

biclotymol

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 5 years

Specifications

Category

Sore throat

Scope of the drug

Ear, Throat, Nose

Release form

Spray

Manufacturer country

France

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Laboratories Bouchara-Recordati

The amount of the dosage form in the primary package

30 g

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antimicrobial agent

Anatomical and therapeutic characteristics

A01AB11 Other preparations

Dosage form

Topical aerosol

Expiration date in days

1825

Dosage (volume) of the substance in the preparation

750 mg

The target audience

Children

Package weight, g

170

Mode of application

:

Adults - 80-120 mg / day, children over 6 years old - 20-60 mg / day.

When administered by inhalation to adults and children, 2 injections 3 times / day.